PACTR202202880140319招募中1 期
Early use of ibuprofen in COVID-19 might a promising agent to attenuate the severity of the disease: A randomized controlled trial
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •1- Age: 18 - 60 years-old both sex
- •2.moderate case covid 19 diseases
排除标准
- •1- Severe case covid disease.
- •2.Advanced liver disease.
- •3- Renal dysfunction.
- •4- History of peptic ulcer.
- •5.History of allergy to ibuprofen or paracetamol.
- •6. Vaccinated patient by any type of vaccine either single or twice dose
研究者
相似试验
招募中
3 期
The effect of premedication on tooth anesthesiaIRCT20131216015814N3Qazvin University of Medical Sciences88
招募中
不适用
Effectiveness of an anti-inflammatory medication on the control of pain before orthodontic separators placement in children and adolescents: a single center randomized controlled trialOral HealthPain experienced by patients undergoing a regular separators placement in preparation for fitting orthodontic bands and bracesPACTR201611001850216El Sahel teaching Hospital60
进行中（未招募）
不适用
Study comparing ibuprofen and ibuprofen arginine in the control of spontaneous pain in patients with osteoarthritis and stabilized hypertension.EUCTR2011-003826-28-ITZAMBON S.p.A.
招募中
2 期
ANIF1 effect on COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20190727044343N3Mazandaran University of Medical Sceinces60
进行中（未招募）
1 期
Safety and Efficacy of Favipiravir in COVID-19 Patients with Pneumonia-A randomized, double blind, placebo- controlled studyPatients diagnosed with COVID-19 by positive PCR for SARS-COV2MedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsEUCTR2020-002753-22-ESFerrer Internacional, S.A.100